Which drug takes advantage of a molecular chaperone strategy
Migalastat
Fabry dz inheritance
X-linked recessive
Fabry dz mutation and result
Inactivating mutation in alpha-galctosidase A leading to sphingolipid accumulation
Why would ERT fail for Niemann-Pick type C
Target enzyme is a membrane protein
Miglustat is a
Glucosylceramide synthase inhibitor…inhibits synthesis of glycosphingolipids in cells
Gaucher’s dz defect
In glucocerebrosidase (GBA)
Gaucher’s symptoms
Bruising, anemia, fatigue, liver and spleen enlargement
Sclera, skeletal probs
What is obstacle to treating neurological symtpims of LSDs
Enzymes are water solbule…only very select hydrophilic molecules can get through BBB